Topic

Aurobindo Pharma

20 articles

Aurobindo Pharma’s API unit in Telangana gets two US FDA observations
Corporate 19 Dec 2024

Aurobindo Pharma’s API unit in Telangana gets two US FDA observations

The US FDA inspected Unit-V, an API manufacturing facility, of Apitoria Pharma, a wholly-owned subsidiary of the company Aurobindo Pharma…

Aurobindo’s subsidiary CuraTeQ obtains exclusive rights for BioFactura’s Ustekinumab biosimilar
Global News 11 Jul 2023

Aurobindo’s subsidiary CuraTeQ obtains exclusive rights for BioFactura’s Ustekinumab biosimilar

CuraTeQ has been granted exclusive license rights to commercialize BFI-751 in all major regulated markets including the US, the EU,…

Aurobindo Pharma Foundation invests Rs 80 cr to build oncology block in Hyderabad
Hospital 18 Apr 2023

Aurobindo Pharma Foundation invests Rs 80 cr to build oncology block in Hyderabad

The state-of-the-art facility span over 2,32,000 sq ft and has a 300- bed capacity Aurobindo Pharma Foundation (APF), the philanthropic…

Biopharma co Evive in licence agreement with Aurobindo’s subsidiary Acrotech Biopharma
Global News 24 Nov 2022

Biopharma co Evive in licence agreement with Aurobindo’s subsidiary Acrotech Biopharma

To commercialise Ryzneuta (Efbemalenograstim alfa) in the US Evive Biotech (Evive), a global biopharmaceutical company devoted to developing novel biologic…

Aurobindo Pharma’s CuraTeQ Biologics to invest around Rs 300 Cr for capacity expansion
News 7 Sep 2022

Aurobindo Pharma’s CuraTeQ Biologics to invest around Rs 300 Cr for capacity expansion

The board also approved entering into CMO for biologicals for effective utilisation of capacities Aurobindo Pharma announced that CuraTeQ Biologics…

Eugia Pharma receives US FDA approval for Bortezomib Injection
News 6 May 2022

Eugia Pharma receives US FDA approval for Bortezomib Injection

The approved product has a market size of $1172 million for the twelve months ending March 2022, according to IQVIA…

Pharma firms recall products from US amid US FDA verification
Global News 25 Apr 2022

Pharma firms recall products from US amid US FDA verification

Aurobindo Pharma, Sun Pharma and Jubilant are the three companies Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products…

Arvind Bothra joins Aurobindo Pharma as Senior Vice President, Head of Investor Relations and Corp Comm
News 31 May 2021

Arvind Bothra joins Aurobindo Pharma as Senior Vice President, Head of Investor Relations and Corp Comm

He is a graduate from Indian Institute of Management and a qualified Chartered Accountant Arvind Bothra has joined Aurobindo Pharma…

India-based drug makers recall products in US market
Global News 15 Mar 2021

India-based drug makers recall products in US market

Sun Pharma, Dr Reddy's Laboratories, Aurobindo Pharma and Jubilant Pharma for some or other reasons Sun Pharma, Dr Reddy's Laboratories,…

Aurobindo Pharma gets US FDA nod for generic Droxidopa capsules
Global News 21 Feb 2021

Aurobindo Pharma gets US FDA nod for generic Droxidopa capsules

The drug is used to treat dizziness and lightheadedness Drug major Aurobindo Pharma has received final approval from the US…